Envista Holdings Corporation (NVST)
NYSE: NVST · Real-Time Price · USD
23.15
-0.07 (-0.30%)
May 18, 2026, 4:00 PM EDT - Market closed
Envista Holdings Revenue
Envista Holdings had revenue of $1.35B in the twelve months ending April 3, 2026, up 9.55% year-over-year.
Revenue (ttm)
$1.35B
Revenue Growth
+9.55%
P/S Ratio
1.34
Revenue / Employee
$234,008
Employees
12,000
Market Cap
3.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 2.57B | 60.20M | 2.40% |
| Dec 31, 2021 | 2.51B | 579.80M | 30.06% |
| Dec 31, 2020 | 1.93B | -355.70M | -15.57% |
| Dec 31, 2019 | 2.28B | -559.70M | -19.68% |
| Dec 31, 2018 | 2.84B | 33.60M | 1.20% |
| Dec 31, 2017 | 2.81B | 25.50M | 0.92% |
| Dec 31, 2016 | 2.79B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Avantor | 6.55B |
| Bausch + Lomb | 5.21B |
| DENTSPLY SIRONA | 3.68B |
| MiniMed Group | 2.99B |
| ICU Medical | 2.16B |
| Teleflex | 2.13B |
| Merit Medical Systems | 1.54B |
| Stevanato Group | 1.39B |
NVST News
- 11 days ago - Envista price target raised to $31 from $30 at Baird - TheFly
- 11 days ago - Envista price target raised to $29 from $26 at JPMorgan - TheFly
- 11 days ago - Envista price target raised to $33 from $30 at Evercore ISI - TheFly
- 12 days ago - Envista Holdings Earnings Call Transcript: Q1 2026 - Transcripts
- 12 days ago - Envista Reports First Quarter 2026 Results - PRNewsWire
- 24 days ago - Envista price target raised to $21 from $19 at Morgan Stanley - TheFly
- 4 weeks ago - Envista initiated with a Neutral at Citi - TheFly
- 5 weeks ago - Envista Schedules First Quarter 2026 Earnings Call - PRNewsWire